Earnings

In a year marked by significant revenue declines for major players in the mRNA and COVID-19 vaccine space, BioNTech SE...

While Wall Street analysts express growing concern over the ballooning infrastructure costs within the artificial intelligence sector, Microsoft continues to...

Alphabet Inc. is reinforcing its leadership in artificial intelligence through substantial capital commitments and significant technological advancements. As the company's...

Take-Two Interactive has closed its books on fiscal year 2026, with investor focus now squarely fixed on the horizon. The...

Biopharmaceutical firm Ocugen is transitioning from clinical development to the regulatory phase, with its lead gene therapy candidate approaching a...

In a rare admission, legendary investor Warren Buffett conceded to a significant error in judgment regarding his stake in Apple...

The advertising technology firm The Trade Desk is experiencing a significant shift in its shareholder base. Despite posting solid operational...

T1 Energy unveiled a substantial set of announcements today, combining quarterly results, a shift in its board leadership, and a...

All eyes are on Tilray Brands this Wednesday as the company prepares to release its third-quarter 2026 financial results. The...

Market experts are growing more optimistic about Cardiff Oncology's financial trajectory. Following the biotechnology firm's stronger-than-anticipated performance in February, analysts...